Bioxodes, a company specializing in the development of therapies for the prevention and treatment of thrombotic and inflammatory diseases, has appointed Marc Dechamps as its new CEO. Company founder, Edmond…
Bioxodes, a company specializing in the development of therapies for the prevention and treatment of thrombotic and inflammatory diseases, has appointed Marc Dechamps as its new CEO. Company founder, Edmond…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


